About this source
- Kind
- Research
- Design
- Human clinical trial, RCT
- Population
- 320 Chinese adults with type 2 diabetes inadequately controlled by diet and exercise alone
- Sample size
- 320
- Primary or secondary
- primary
- Peer review
- peer reviewed
- Retraction status
- None known
- Date checked
- 14 November 2026
Limitations
Chinese population, mazdutide alone, 24-week placebo-controlled period. Funded by Innovent Biologics. Abstract read via Europe PMC; full text not read.
Cited in
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.